Browse Articles
Discover research articles across all indexed journals
Iron‐Hijacking Trojan Horse Nanoplatform Combats Implant‐Associated Biofilm Infections Through Immuno‐Fibrotic Remodeling
ABSTRACT Implant‐associated biofilm infections persist due to a vicious cycle of biofilm resilience and fibrosis‐driven immune exclusion. To break this cycle, we engineered a photothermal nanoplatform (CHPB@H) consisting of curcumin‐loaded hollow Prussian blue (CHPB) nanoparticles embedded in an injectable thermosensitive chitosan hydrogel for near‐infrared (NIR)‐triggered local delivery. Upon NIR irradiation, the platform releases iron ions and curcumin that self‐assemble into Fe‐curcumin (Fe‐Cur) complexes. These complexes act as a molecular “Trojan horse” that hijacks bacterial iron‐acquisition pathways to induce ferroptosis. Concurrently, CHPB scavenges reactive oxygen species (ROS) via its intrinsic nanozyme activity and suppresses oxidative stress‐driven fibroblast activation, thereby dismantling the fibrotic barrier that excludes immune effector cells. This dual action eliminates biofilms and restores immune cell infiltration into the infection site. In preclinical animal models, the therapy clears established implant infections, remodels the immune‐fibrotic microenvironment, and promotes tissue regeneration. This work establishes a “clear‐and‐remodel” paradigm that integrates active targeted ferroptosis (via iron hijacking) with immuno‐fibrotic remodeling, offering a translatable strategy for complex implant‐associated biofilm infections.
The transcriptional repressor PheR regulates uptake and catabolism of phenanthrene in Sphingobium sp. SHPJ-2
Automated cancer data extraction using large language models: A scalable workflow for clinical documentation processing.
15 Background: Accurate and timely capture of key diagnosis variables including ICD-10-AM codes, histology, laterality and diagnosis date are essential for cancer registry reporting, research and service planning. Current curation workflows use manual review of clinical and histopathology documents for the approximately 1000 cancer patients diagnosed monthly at National Cancer Centre Singapore, resulting in substantial workload and data latency of up to six months. Scalable automation is therefore critically needed. Methods: We developed and evaluated an automated extraction pipeline using large-language models (LLMs) to generate structured cancer diagnosis data from unstructured clinical text. A structured prompt engineering framework incorporating multi-stage task decomposition, reference-grounded generation, and few-shot learning was designed to enforce strict medical coding constraints, anatomical consistency, and source hierarchy. An institutional in-house model (GPT-5) processed retrieved clinical documents to extract ICD-10-AM codes, histology, laterality and diagnosis dates. Results were independently adjudicated by a trained cancer informatician and oncologist. Based on initial adjudication, pre-defined criteria were developed to identify complex/ambiguous cases for manual review to enhance accuracy. Model performance was evaluated using accuracy, recall, precision and F1 score. Results: Two cohorts were analysed: Cohort A (360 patients, 444 cancer diagnoses across 30 selected cancers) diagnosed January 2018 to December 2024, Cohort B (359 patients, 415 diagnoses in an unselected cohort) diagnosed between January to April 2025. The pipeline processed each cohort within 136-144 minutes; 23.3% (84/360) and 23.1% (83/359) in Cohorts A and B respectively were flagged for human-in-the-loop review based on predefined complex/ambiguous case criteria. Model performance for cohort processed end-to-end without manual intervention is presented in Table 1. Conclusions: Our LLM-based extraction pipeline accurately captured cancer diagnosis information from clinical documentation, reducing manual workload and shortening data latency. Cohort B demonstrated superior performance, attributable to lower document volume and reduced clinical documentation complexity which improved signal clarity and extraction accuracy. Embedded quality control criteria incorporating human-in-the-loop effectively identified complex or ambiguous cases for expert review, supporting scalable cancer registry operations with strong potential for broader healthcare implementation. Model performance. Cohort Overall Accuracy ICD-10-AM Histology Laterality Diagnosis Date Accuracy Recall Precision F1 score Accuracy Accuracy Accuracy Cohort A 0.840 0.965 0.965 0.976 0.971 0.956 0.970 0.955 Cohort B 0.915 0.996 0.996 1.000 0.998 0.927 0.973 0.990
BC008-1A (PD-1/TIGIT bispecific antibody) in recurrent CNS WHO grade 4 glioma: Results from a randomized phase I study.
71 Background: Dual blockade of PD-1 and TIGIT may overcome T-cell exhaustion in glioma. BC008-1A is a humanized PD-1/TIGIT bispecific antibody. We report antitumor activity from two dose cohorts in recurrent CNS WHO grade 4 glioma. Methods: In this open-label, randomized phase I study, adults with histologically confirmed recurrent CNS WHO grade 4 glioma with RANO-confirmed progression after standard therapy, no surgical plan, KPS≥70, life expectancy ≥12 weeks, and ≥1 measurable intracranial lesion by RANO were randomized 1:1 to BC008-1A 900 mg or 1200 mg IV q3w (21-day cycles). Primary endpoint was safety (AEs/SAEs; TEAEs graded per NCI-CTCAE v5.0). Secondary endpoints included ORR/DCR, TTR, DOR, PFS and OS. Results: At data cutoff 22 Jan 2026, 20 patients were treated (900 mg 10; 1200 mg 10). Median age 54 years (range 21–67); IDH-wildtype 18/20. Safety: no DLTs; grade ≥3 TRAEs [16.7]%; no serious TRAEs or treatment-related deaths. Efficacy: Median follow-up 5.6 months. Overall, PR 8/20 (ORR 40%), SD 5/20, PD 7/20 (DCR 65%). ORR was 50% (900 mg) and 30% (1200 mg). Best tumor shrinkage among responders reached 96.9% (range 81.9–96.9%). Median TTR was 2.1 months (range 0.7–4.1). DOR was up to 18 weeks, with 2 responses ongoing at cutoff. PFS events occurred in 6 patients. Conclusions: BC008-1A showed manageable safety and objective responses across 900–1200 mg in recurrent grade 4 glioma, supporting further evaluation with integrated PK and biomarker analyses. Clinical trial information: NCT06773481 .
Nuclear-specific reductive carboxylation of alpha-ketoglutarate fuels histone acetylation to induce chromatin accessibility and gene activation
Abstract Mitochondria remain at the core of cell metabolism, whereas the nucleus integrates cellular and environmental signals to activate genes. However, the mechanisms that directly link cellular metabolism to gene regulation are not well understood. Here we show, a metabolic pathway in the nucleus controls acetylation of histones by nuclear localization of mitochondrial enzymes aconitase (ACO2) and isocitrate dehydrogenase (IDH2). Metabolic tracing studies show that IDH2 and ACO2 catalyze reductive carboxylation of α-ketoglutarate to rapidly synthesize citrate to increase nuclear acetyl-CoA pool. Genetic and proteomic analyses reveal nuclear IDH2 and ACO2 form a complex with KAT2A/GCN5 for acetylation of histones to increase chromatin accessibility and activation of proliferative genes. Robust nuclear expressions of ACO2 and IDH2 drive aggressive tumors indicating the tumorigenic potential of IDH2-ACO2-KAT2A axis. Altogether, our work reveals a paradigm coupling a nuclear metabolic pathway with histone acetylation to control of gene expression that accentuates hyperproliferative phenotype in tumors.
Functional data analysis of college students’ sleep patterns and their relationships with academic performance and social networks: A four-year longitudinal study
Background College students are subject to insufficient sleep and irregular sleep patterns. Most existing studies regarding sleep behaviors have relied on static measures or discrete time points for analyzing sleep data, potentially missing the dynamic and continuous nature of sleep behavior. Objectives To examine sleep pattern evolution and their relationships with academic performance and social networks among college students using functional data analysis. Methods This study introduces functional data analysis to examine sleep patterns and their relationships with academic performance and social networks among college students throughout their four-year undergraduate experience. Using data from the NetHealth Project, we analyzed daily sleep records from Fitbit devices worn by 76 undergraduate students, along with their academic records and social network data, comprising 61,225 daily observations. We employed functional regression to model time-varying relationships between sleep and GPA, and functional t-tests to compare sleep patterns between students with different social activity levels. Results Sleep duration increased significantly across the undergraduate years, with pronounced seasonal fluctuations corresponding to academic cycles. The relationship between sleep and academic performance remained consistently positive throughout college, with each GPA point associated with 27.4 additional minutes of sleep on average. This relationship exhibited a U-shaped temporal pattern, strongest during freshman year (54 minutes/GPA point), weakest during junior year (5 minutes/GPA point), and recovering during senior year (48 minutes/GPA point). Social network characteristics showed no statistically significant associations with sleep patterns, though students with larger networks consistently slept slightly less than those with smaller networks. Conclusions This study demonstrates the utility of functional data analysis in sleep research, revealing dynamic patterns in sleep behavior and time-varying relationships with academic performance that traditional discrete-time analyses would not capture. The consistently positive association between sleep duration and academic performance was maintained throughout the four-year undergraduate experience, with temporal variations suggesting the relationship is strongest during freshman and senior years. These findings provide longitudinal evidence about sleep patterns and their correlates among college students, with potential implications for the timing of sleep-related support services.
A Paintable Bioinspired Stratified Skin Resolving the Cooling‐Electricity Trade‐Off for All‐Weather Building Retrofits
ABSTRACT Passive daytime radiative cooling (PDRC) can mitigate heat stress by dissipating heat into cold outer space, yet its benefit is suppressed by rainfall and by overcooling at higher latitudes. To offset these limitations, globally distributed rainfall can be harnessed for complementary electricity generation via a droplet electricity generator (DEG). However, integrating DEG with PDRC while preserving both cooling and electrical performance remains challenging. Inspired by Tillandsia trichomes, we report a paintable bifunctional skin that resolves this trade‐off through stratified organization and functional reuse. A fluorinated top layer enables repeatable droplet electrification and self‐cleaning while preserving strong mid‐infrared emission, whereas nanoparticle‐based layers simultaneously provide broadband solar scattering and dielectric charge storage. Guided by Monte Carlo simulations, this skin exhibits 96.2% solar reflectance and 96.5% thermal emissivity, delivers a peak net cooling power of 104 W m −2 , and sustains outdoor sub‐ambient cooling of up to 9.5°C for more than six months. During rainfall, it reaches a peak electrical power density of 357 W m −2 . Global modeling across 1803 cities predicts a 33.9% expansion in the latitude span of net‐positive annual benefit relative to standalone PDRC, offering a scalable route toward all‐weather, latitude‐robust building retrofits.
Distinct Nuclear Localization Signals Confer Differential Microtubule Dependence among ZFTA Fusion Oncoproteins
Ultra-specific high-multiplex PCR liquid biopsy assays to enable high-frequency treatment and disease monitoring in urothelial malignancies.
186 Background: In urothelial cancer, several high-impact decisions are made with limited real-time molecular evidence of residual disease or treatment response. In non–muscle-invasive bladder cancer (NMIBC), early repeat TURBT is often performed due to concern for residual tumor, and response to intravesical BCG is typically assessed only after completion of induction—potentially delaying escalation to salvage therapy or consideration of radical cystectomy when indicated. Tumor-informed NGS MRD can be useful, but cost and turnaround time may limit sampling frequency. A rapid, quantitative, highly sensitive and specific PCR-based liquid biopsy assay platform could support earlier escalation/de-escalation decisions. Deep multiplexing may further reduce per-test reaction burden by compacting panels into a single/few PCR reaction chambers. Methods: An emerging platform (Infiniplex) combines: (1) ultra-specific allele-selective primer design for single-nucleotide variants (SNVs), with extensions to additional mutation classes and methylation targets, compatible with qPCR and d/ddPCR; This, in turn, facilitates (2) deep-combinatorial multiplexing schemes that enable deconvolution of co-expressed mutations from a single/few wells. Analytical performance was assessed using contrived variant mixtures and relevant liquid biopsy matrices (urine and plasma), with a focus on sensitivity, specificity, and multiplex decoding robustness. Outputs are designed for serial quantification to generate molecular response trajectories (decay/plateau/rise). Results: Ultra-specific SNV assays achieved detection down to 0.1–0.01% VAF in liquid biopsy workflows, supporting applications where very low-frequency variants are clinically relevant. Combinatorial multiplexing enabled practical high-multiplex panel designs while maintaining rapid turnaround suitable for frequent longitudinal testing. In NMIBC, proposed clinical readouts include: (i) post-TURBT urine monitoring to help identify patients most likely to benefit from repeat TURBT; (ii) early BCG response/failure trend assessment after ≥3 instillations to support earlier therapy adaptation; and (iii) urine-based molecular trajectories to inform discussions around escalation to definitive management in BCG unresponsive NMIBC. Conclusions: A combinatorial, ultra-specific qPCR/dPCR platform may enable increased frequency of bladder cancer liquid biopsy monitoring with low cost and fast turnaround, without compromising analytical sensitivity or specificity. Prospective clinical studies are planned to establish actionable thresholds and outcome-linked performance at key NMIBC decision points.
Long-term survival analysis of TNT: A phase II study of neoadjuvant toripalimab plus nimotuzumab combined with taxol-based chemotherapy in locally advanced penile squamous cell carcinoma.
177 Background: Locally advanced penile squamous cell carcinoma (La-PSCC) is an aggressive malignancy, and the previous standard neoadjuvant TIP regimen has shown moderate efficacy and unfavorable survival outcomes, with an objective response rate (ORR) of 50%, a pathological complete response (pCR) rate of 10%, and median progression-free survival (PFS) and overall survival (OS) of 8.1 months and 17.1 months, respectively. Our preliminary results of the TNT regimen showed promising efficacy, with an ORR of 82.8% and a pCR rate of 48.3%. Here, we present the long-term survival results of this trial with a long time follow-up. Methods: In this multi-center study, single-arm, phase II study, eligible patients with histologically confirmed La-PSCC (cT4/cN3) received TNT regimen (comprising toripalimab, nimotuzumab, and TIP chemotherapy [nab-paclitaxel, cisplatin, and ifosfamide]) every 3 weeks for up to 4 cycles, followed by consolidative surgery. While the primary endpoint was pCR (previously reported), this updated analysis focuses on secondary endpoints, including PFS and OS. The data cutoff date for this analysis was February 10, 2026. Results: With a median follow-up of 59.3 months (range, 2.33-66.93), median PFS and mOS were not reached for the cohort (n=29). The estimated 5-year PFS and OS were 65.5% (95%CI: 50.3%–85.3%) and 69.0% (95%CI: 54.1%–88.2%), respectively. Survival outcomes were significantly stratified by treatment response. In patients achieving a pCR (n=14), the median PFS and OS were not reached. Whereas the non-pCR group (n=15) showed mPFS of 9.7 months (95%CI: 5.63–not reached[NR]) (HR=0.08; 95%CI: 0.009–0.616; p=0.002) and mOS of 33.4 months (95%CI: 12–NR) (HR=0.10; 95%CI: 0.012–0.771; p=0.006). Responders (those achieving a complete response [CR] or partial response [PR], n=24) exhibited significantly better outcomes than non-responders (n=5, all experienced disease progression and death), with median PFS not reached vs 2.47 months (95% CI: 1.7–NR) (HR=0.031, 95%CI: 0.006–0.169, p<0.001) and median OS not reached vs 10.5 months (95% CI, 6.93–NR) (HR=0.033, 95%CI: 0.006–0.181, p<0.001). No new safety signals emerged during the near 5-year follow-up. Conclusions: With a median follow-up of 59.3 months, the TNT regimen continued to provide clinically superior survival outcomes in patients with locally advanced PSCC, maintained by a favorable safety profile. Our findings confirm the long-term durability of TNT regimen, reinforcing its role as a highly effective neoadjuvant strategy for these patients. Clinical trial information: NCT04475016 .
A sequential MAP kinase cascade regulates mechanical signalling
Abstract Plants respond to mechanical stimulations like wind, touching or wounding to safeguard their development and survival. Mitogen Activated Protein Kinases (MAPKs) activation by mechanostimuli was reported 26 years ago, but the upstream regulatory mechanism and function remained unknown. We report that mechanostimulation activates a MAPKKK3/4/5-MKK4/5-MPK3/6 cascade within 60 seconds, leading to induction of ~800 genes, encompassing most of the early touch response. Most genes overlap with touch-responsive genes regulated by CAMTA1/2/3, exposing an interplay between MAPKs and CAMTA transcription factors. Furthermore, loss of MKK4/5 leads to global impairment of touch-regulated protein phosphorylation, demonstrating they are crucial regulators. In contrast, phosphorylation does not clearly affect early activation of the touch-induced jasmonic acid (JA) signalling pathway, nor does loss of JA affect the overall early touch-phosphoproteome. Lastly, loss of MAPKKK3/4/5 and MKK4/5 reduces thigmomorphogenesis, underlining the importance of the identified MAPK cascade for steering plant growth during stress. In summary, we have now identified a MAPKKK3/4/5-MKK4/5-MPK3/6 cascade as a key touch- and wounding signalling pathway in plants.
A Dinucleating Modular Phosphine–Pyridine–Oxazoline Ligand for Cu-Catalyzed Asymmetric Dearomative Propargylic Substitutions
Determinants of mobile money loan disbursements: Evidence from Uganda’s post pandemic digital credit boom
In the aftermath of the COVID-19 pandemic, Uganda witnessed a rapid rise in mobile money usage and digital credit adoption, underscoring the sector’s role in post crisis recovery and financial resilience. Against this backdrop, this paper examines the determinants of mobile money loan disbursements in Uganda a global pioneer in mobile financial innovation, using monthly data from July 2021 to December 2024 and applying the Autoregressive Distributed Lag (ARDL) cointegration framework to capture both long-run relationships and short-run dynamics. Results show a long-run relationship linking average loan disbursements with outstanding loan values and lagged inflation. In the short term, past loan disbursements have a significant impact on current loan values. Behavioural proxies are informative, airtime purchases and timely mobile loan repayments are associated with higher disbursement volumes, consistent with lenders interpreting them as signals of reliability and liquidity. By contrast, higher transaction volumes and fees depress disbursements, underscoring the adverse impact of elevated user costs on credit access. These findings highlight actionable levers for expanding responsible digital credit and deepening inclusion.
Unusual Anti‐Thermoplastics and Low Thermal Expansion in 2D Metal Halide Crystals
ABSTRACT Zero thermal expansion (ZTE) materials are critically important in numerous scientific and technical applications due to their versatile physical properties. However, these materials are predominantly inorganic oxides and metal alloys, while the intrinsically ZTE molecule‐based single crystals remain exceptionally scarce. This scarcity arises from the lack of a comprehensive understanding of molecular deformation and spatial orientation, which are governed by the intricate coupling between molecular dynamics and intermolecular interactions. Herein, we have presented the linear ZTE and unusual anti‐thermoplastics in a two‐dimensional metal‐halide crystal of G 3 Sb 2 Br 9 ( GSB , where G is guanidinium). GSB exhibits linear ZTE along the a ‐axis and b ‐axis ( α a = 1.77 × 10 −6 K −1 , α b = 1.76 × 10 −6 K −1 ) between 150 and 400 K, being comparable with several heterogeneous metal alloys ( e.g ., LaFe 54 Co 3.5 Si 3.35 ). This behavior can be attributed to the wine‐rack motions, which produce compensatory effects between angular contraction of the inorganic framework and bond elongation. More interestingly, the crystal exhibits anti‐thermoplastic above 420 K, with both its hardness and Young's modulus increasing significantly. 2D metal‐halide molecular crystals combining ultralow in‐plane thermal expansion and anti‐thermoplastics are rarely reported. This work expands the scope of ZTE‐active materials and provides a material platform for studying thermal‐stiffening in soft metal‐halide frameworks.
Solvent‐Mediated Reactivity Control of Lewis‐Paired Dopants as a Versatile Strategy for Tunable and Stable Doping of Organic Semiconductors
ABSTRACT The Lewis pairing between existing dopant molecules offers great potential for developing new organic dopants with exceptional doping strength and stability. However, the high reactivity of Lewis‐paired dopants complicates doping‐level control, while the use of non‐orthogonal solvents can damage organic semiconductor (OSC) films, hindering device applications. Here, the dopant reactivity is controlled by regulating the association–dissociation kinetics among pairing dopants and solvent molecules, which are strongly influenced by solvent polarity. In highly polar solvents, Lewis acid–solvent adducts predominantly form, suppressing the generation of Lewis‐paired dopants. As solvent polarity decreases, the dissociation rate of the Lewis acid–solvent adduct increases, establishing a dynamic equilibrium between the Lewis acid and the solvent and thereby optimizing reactivity. Consequently, the optimally processed Lewis‐paired dopant enables efficient doping of various OSCs with finely tunable doping levels, simultaneously achieving a high thermoelectric power factor (170 µW m −1 K −2 ) and Seebeck coefficient (227 µV K −1 ). These performances surpass those of the conventional salt‐type FeCl 3 dopant and exhibit markedly improved doping stability under ambient and elevated‐temperature conditions. This study provides a practical strategy for utilizing Lewis‐paired dopants by elucidating their doping mechanisms, paving the way to overcome long‐standing limitations in OSC doping.
Conditional dependency of oncogenic KRAS in driving ketone body catabolism and pancreatic cancer growth
Diagnostic accuracy of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer patients: A single-institutional experience.
47 Background: Sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (NACT) is a critical tool for axillary staging in breast cancer. Performance of SLNB after NACT has been an area of interest of late and is still evolving. This study evaluates the feasibility, outcomes, and diagnostic accuracy of SLNB after NACT at our institution. Methods: We analysed 38 female patients with non-metastatic breast cancer who received NACT followed by surgery. All patients underwent dedicated axillary ultrasound +/- fine-needle aspiration cytology (FNAC) prior to NACT.All patients with positive node underwent marking of the most suspicious node to help in Targeted Axillary Dissection (TAD), post chemotherapy. The diagnostic accuracy of SLNB was determined by comparing SLNB results with completion axillary dissection in node positive patients. Results: The mean patient age was 57.8 years. The cohort included 35.7% triple-negative (TNBC), 28.6% hormone receptor-positive (HR+), and 25.0% HER2-positive tumours with 31 patients having cT2 disease. Ten patients had upfront nodal involvement confirmed with FNAC (all were cN1) with nodal clipping done prior to chemotherapy Following NACT, all 38 patients underwent SLNB, with a 100% identification rate and mean of 3 nodes per patient. Among patients with FNAC positive nodes, the TAD node and SLNB node were the same in all 10 patients. Only 5 patients had positive SLNB .Among the 10 patients with positive nodal FNAC, 5 had complete pathological response in SLNB as well as rest of axillary dissection, while 3 had only SLNB being positive and 2 had positive nodes in the rest of the axilla also. A pathological complete response (pCR; ypT0N0) was achieved in 50% of patients SLNB detected all patients who had axillary disease, even in node positive patients with false negative rate of zero. Conclusions: In our experience, SLNB after NACT is a feasible and accurate procedure for axillary staging. These findings support using SLNB to de-escalate axillary surgery in patients who respond well to NACT, minimising morbidity without compromising oncologic safety. Demography and performance of SLNB post NACT. Parameters Values [numbers (percentage)] cT1 7 (18.43%) cT2 31 (81.57%) cN0 28 (73.68%) cN1 10 (26.32%) Average Number of sentinel nodes identified/patients 3 Identification rate 100% SLNB positivity rate 5 (13.16%) Non sentinel node positive 2 among 5 of SLNB+ False Negative rate 0
Effectiveness and safety of traditional Chinese medicine external wash combined with local cooling in preventing UTD1-induced peripheral neuropathy in breast cancer patients: A single-arm, phase II preliminary study.
50 Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a prevalent and debilitating toxicity associated with many anticancer agents, frequently leading to dose reduction, treatment delay, or even discontinuation, thereby compromising clinical outcomes. For patients with advanced breast cancer receiving utidelone (UTD1), a next-generation microtubule inhibitor, similar with Ixabepilone, significantly improved the prognosis in advanced breast cancer in BG01-1323L trial. However, the incidence of CIPN reached 85.4%, with 25.1% being grade ≥3 events, underscoring a significant unmet need for effective prevention. Currently, no standardized preventive strategy exists. Traditional Chinese medicine (TCM) external wash with Huangqi Guizhi Wuwu decoction and local cooling have shown potential in preventing CIPN; however, the combined efficacy and safety of these interventions specifically in UTD1-treated patients remain unexplored. Methods: This single-center, single-arm, phase II study enrolled patients with recurrent or metastatic breast cancer who were scheduled to receive UTD1-based chemotherapy (30–40 mg/m² on days 1-3 & 8-9, or days 1-2 & 8-10, every 3 weeks). All patients received the combined intervention, which consisted of local cooling applied via a temperature-controlled device during UTD1 infusion, plus daily external wash with a modified Huangqi Guizhi Wuwu decoction starting from cycle 1 day 1 until completion of chemotherapy (for up to 6 cycles). CIPN was assessed using the NCI-CTC criteria. The primary objective was to evaluate the incidence and severity of CIPN. Results: As of September 2025, 48 patients were evaluable for CIPN analysis. The median age was 56 years (range, 32-74). Over 85% of patients had received ≥3 prior lines of therapy. The overall incidence of CIPN was 62.5% (30/48), with all cases being grade 1-2. Notably, no grade ≥3 CIPN events were observed (0%), compared to 25.1% reported in the historical phase III trial. Compared to the phase III data (N=267, overall CIPN incidence 85.4%), this combined intervention was associated with a statistically significant reduction in overall CIPN incidence (62.5% vs. 85.4%; P<0.001). Conclusions: Preliminary data from this study suggest that the combination of TCM external wash and local cooling significantly reduces the incidence and severity of UTD1-induced CIPN, completely preventing grade ≥3 events. This preventive benefit persisted after UTD1 dose adjustment, no preliminary antitumor efficacy compromise; detailed analyses ongoing. These promising results warrant further RCTs to confirm this modality’s efficacy in UTD1 regimens. Given shared neurotoxicity mechanisms, this non-pharmacological strategy may apply to other regimens with CIPN as a dose-limiting concern.